Gregory Scott

Gregory Scott is an accomplished professional with extensive experience in commercial strategy and program management within the biopharmaceutical and biotechnology sectors. Currently serving as Vice President of Global Commercial Strategy & Operations at FUJIFILM Diosynth Biotechnologies since January 2023, Gregory has held key leadership roles at Vibalogics as Global Head of Commercial Program Management and at Thermo Fisher Scientific as Director of Project Portfolio Management for the Viral Vector Services unit. Previous positions include senior roles at Brammer Bio, Sandoz, Renaissance, DPT Laboratories, and Bristol-Myers Squibb, where Gregory demonstrated expertise in project execution, product portfolio management, and cross-functional team leadership. Gregory holds an MBA from the Questrom School of Business at Boston University and a B.S. in Mechanical Engineering from Union College.